262 related articles for article (PubMed ID: 2167366)
1. Vasoactive intestinal peptide stimulation of human renal adenylate cyclase in vitro.
Charlton BG; Neal DE; Simmons NL
J Physiol; 1990 Apr; 423():475-84. PubMed ID: 2167366
[TBL] [Abstract][Full Text] [Related]
2. Vasoactive intestinal polypeptide regulation of rabbit renal adenylate cyclase activity in vitro.
Griffiths NM; Simmons NL
J Physiol; 1987 Jun; 387():1-17. PubMed ID: 3656172
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal peptide control of renal adenylate cyclase: in vitro studies of canine renal membranes and cultured canine renal epithelial (MDCK) cells.
Griffiths NM; Rugg EL; Simmons NL
Q J Exp Physiol; 1989 May; 74(3):339-53. PubMed ID: 2546173
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal peptide stimulation of adenylate cyclase activity in isolated rabbit renal arterial microvessels.
Griffiths NM; Simmons NL
Exp Physiol; 1990 Jul; 75(4):601-4. PubMed ID: 2223058
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide stimulation of renal adenylate cyclase and antagonism by (4Cl-D-Phe6Leu17)VIP.
Griffiths NM; Simmons NL; Rivier J
Pflugers Arch; 1989 Jun; 414(2):222-7. PubMed ID: 2755776
[TBL] [Abstract][Full Text] [Related]
6. A cultured human renal epithelioid cell line responsive to vasoactive intestinal peptide.
Simmons NL
Exp Physiol; 1990 May; 75(3):309-19. PubMed ID: 2161676
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of the adenylyl cyclase activity in human endometrial membranes by VIP and related peptides.
Bajo AM; Guijarro LG; Juarranz MG; Valenzuela P; Martinez P; Prieto JC
Biosci Rep; 1993 Apr; 13(2):69-77. PubMed ID: 8397008
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide receptor antagonists in rat seminal vesicle membranes.
RodrÃguez-Pena MS; Guijarro LG; Prieto JC
Eur J Pharmacol; 1991 Nov; 208(3):207-12. PubMed ID: 1663044
[TBL] [Abstract][Full Text] [Related]
9. Effect of freezing on the coupling of VIP receptors to adenylate cyclase in rat liver membranes.
Robberecht P; Waelbroeck M; De Neef P; Camus JC; Gourlet P; Christophe J
Life Sci; 1988; 42(5):505-10. PubMed ID: 2828794
[TBL] [Abstract][Full Text] [Related]
10. Distribution of vasoactive intestinal peptide-sensitive adenylate cyclase activity along the rabbit nephron.
Griffiths NM; Chabardès D; Imbert-Teboul M; Siaume-Perez S; Morel F; Simmons NL
Pflugers Arch; 1988 Sep; 412(4):363-8. PubMed ID: 3174393
[TBL] [Abstract][Full Text] [Related]
11. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
Christophe J; Waelbroeck M; Chatelain P; Robberecht P
Peptides; 1984; 5(2):341-53. PubMed ID: 6089134
[TBL] [Abstract][Full Text] [Related]
12. Interactions between vasoactive intestinal peptide and dopamine in the rabbit retina: stimulation of a common adenylate cyclase.
Pachter JA; Lam DM
J Neurochem; 1986 Jan; 46(1):257-64. PubMed ID: 2415680
[TBL] [Abstract][Full Text] [Related]
13. Cerebral vascular adenylate cyclase: evidence for coupling to receptors for vasoactive intestinal peptide and parathyroid hormone.
Huang M; Rorstad OP
J Neurochem; 1984 Sep; 43(3):849-56. PubMed ID: 6086840
[TBL] [Abstract][Full Text] [Related]
14. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes.
Mittag TW; Tormay A; Podos SM
J Pharmacol Exp Ther; 1987 Apr; 241(1):230-5. PubMed ID: 3033201
[TBL] [Abstract][Full Text] [Related]
16. Bicarbonate secretion in the guinea pig duodenum: functional characterization of peptide hormone receptors in duodenal enterocytes.
Reimer R; Odes HS; Beil W; Schwenk M; Muallem R; Sewing KF
Pharmacology; 1996 Jun; 52(6):339-46. PubMed ID: 8844783
[TBL] [Abstract][Full Text] [Related]
17. Interaction of vasoactive intestinal peptide with a cell line (HeLa) derived from human carcinoma of the cervix: binding to specific sites and stimulation of adenylate cyclase.
Prieto JC; Guerrero JM; de Miguel C; Goberna R
Mol Cell Biochem; 1981 Jul; 37(3):167-76. PubMed ID: 6268963
[TBL] [Abstract][Full Text] [Related]
18. Development of vasoactive intestinal peptide-responsive adenylate cyclase during enterocytic differentiation of Caco-2 cells in culture. Evidence for an increased receptor level.
Laburthe M; Rousset M; Rouyer-Fessard C; Couvineau A; Chantret I; Chevalier G; Zweibaum A
J Biol Chem; 1987 Jul; 262(21):10180-4. PubMed ID: 3038870
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal peptide (VIP) and peptide having N-terminal histidine and C-terminal isoleucine amide (PHI) stimulate adenylate cyclase activity in human heart membranes.
Taton G; Chatelain P; Delhaye M; Camus JC; De Neef P; Waelbroeck M; Tatemoto K; Robberecht P; Christophe J
Peptides; 1982; 3(6):897-900. PubMed ID: 6897744
[TBL] [Abstract][Full Text] [Related]
20. A fragment of vasoactive intestinal peptide, VIP(10-28), is an antagonist of VIP in the colon carcinoma cell line, HT29.
Turner JT; Jones SB; Bylund DB
Peptides; 1986; 7(5):849-54. PubMed ID: 3025826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
